Souhaitez-vous accéder aux communiqués récents ?
Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.
-
PETALUMA, Calif., Sept. 24, 2015 (GLOBE NEWSWIRE) -- Oculus Innovative Sciences, Inc. (NASDAQ:OCLS) (tradable warrants OCLSW), a specialty pharmaceutical company that develops and markets solutions...
-
MIAMI BEACH, Fla., Sept. 24, 2015 (GLOBE NEWSWIRE) -- Many dieters are turning to fat blockers for their ability to prevent the body from absorbing fat consumed in the daily diet, resulting in more...
-
PARIS and BOSTON, Sept. 24, 2015 (GLOBE NEWSWIRE) -- NEOVACS (Alternext Paris:ALNEV), a leader in active immunotherapies for the treatment of autoimmune diseases, announced today it has begun...
-
CAMBRIDGE, Mass., Sept. 23, 2015 (GLOBE NEWSWIRE) -- Vericel Corporation (NASDAQ:VCEL), a leading developer of patient-specific expanded cellular therapies for the treatment of severe diseases and...
-
SANTA BARBARA, Calif., Sept. 23, 2015 (GLOBE NEWSWIRE) -- Sientra, Inc. (NASDAQ:SIEN), a medical aesthetics company, today announced the closing of its follow-on public offering of 3,000,000 shares of...
-
NEW YORK, NY, Sept. 23, 2015 (GLOBE NEWSWIRE) -- Provista Diagnostics, Inc., a privately-held molecular diagnostics company focused on developing and commercializing a new generation of proprietary...
-
AUSTIN, Texas, Sept. 23, 2015 (GLOBE NEWSWIRE) -- Medical Marijuana, Inc. (OTC Pink:MJNA) and SmallCapVoice.com, Inc. (SCV) announced today that a new audio interview with Medical Marijuana, Inc., a...
-
SAN DIEGO, Sept. 23, 2015 (GLOBE NEWSWIRE) -- As the U.S. territories and Caribbean Islands wait for medical marijuana to make its debut, Medical Marijuana, Inc. (OTC Pink:MJNA) is proud to...
-
DURHAM, N.C., Sept. 23, 2015 (GLOBE NEWSWIRE) -- Argos Therapeutics Inc. (Nasdaq:ARGS) ("Argos"), an immuno-oncology company focused on the development and commercialization of fully individualized...
-
PHILADELPHIA, Sept. 23, 2015 (GLOBE NEWSWIRE) -- Hemispherx Biopharma (NYSE MKT:HEB) announced today a new peer reviewed article, with senior authors from the Italian Ministry of Health and other...